Corilagin Protects Against HSV1 Encephalitis Through Inhibiting the TLR2 Signaling Pathways In Vivo and In Vitro. [electronic resource]
- Molecular neurobiology Dec 2015
- 1547-1560 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1559-1182
10.1007/s12035-014-8947-7 doi
Animals Antiviral Agents--pharmacology Brain--metabolism Cells, Cultured Down-Regulation--drug effects Encephalitis, Herpes Simplex--prevention & control Glucosides--pharmacology Herpesvirus 1, Human Hydrolyzable Tannins--pharmacology Interleukin-6--biosynthesis Intracellular Signaling Peptides and Proteins--biosynthesis Lipopeptides--toxicity Male Membrane Glycoproteins--biosynthesis Mice Mice, Inbred BALB C Microglia--drug effects Myeloid Differentiation Factor 88--biosynthesis NF-kappa B--biosynthesis Nerve Tissue Proteins--biosynthesis Phosphorylation--drug effects Protein Processing, Post-Translational--drug effects RNA Interference RNA, Messenger--biosynthesis RNA, Small Interfering--genetics Receptors, Interleukin-1--biosynthesis Signal Transduction--drug effects TNF Receptor-Associated Factor 6--biosynthesis Toll-Like Receptor 2--antagonists & inhibitors Tumor Necrosis Factor-alpha--biosynthesis p38 Mitogen-Activated Protein Kinases--genetics